INTRODUCTION: Meningiomas are slow growing primary central nervous system (CNS) tumours attached to the duramater, which arise from the meningothelial cells of the arachnoid. Grading of meningioma based on histological findings assisted with supplementary immunohistochemical studies, predicts the prognosis of meningioma with good precision. AIM: To evaluate proliferative markers and correlate with various histological subtypes and grade. MATERIALS AND METHODS: A total of 224 meningiomas, diagnosed between January1995 and October 2011were graded according to WHO 2007 criteria. Immunostaining for p53 and Ki-67 markers were performed on 100 cases. RESULTS: There was female predominance. There were 194 Grade I, 24 Grade II and 6 Grade III meningiomas. Brain invasion noted in 18(8%) meningiomas predominantly in grade III followed by grade II. Recurrence was seen in 7 (3.1%) cases, most common in psammomatous followed by angiomatous meningioma. Immunostaining showed p53 positivity in 72.5% of grade I, 83.3% of grade II and all the cases of grade III tumours. Ki-67 Labelling Index (LI) consistently increased from grade I to grade III tumours. CONCLUSION: p53 and Ki-67 LI correlated well with increasing histological grade and biological behaviour of meningioma.
INTRODUCTION:Meningiomas are slow growing primary central nervous system (CNS) tumours attached to the duramater, which arise from the meningothelial cells of the arachnoid. Grading of meningioma based on histological findings assisted with supplementary immunohistochemical studies, predicts the prognosis of meningioma with good precision. AIM: To evaluate proliferative markers and correlate with various histological subtypes and grade. MATERIALS AND METHODS: A total of 224 meningiomas, diagnosed between January1995 and October 2011were graded according to WHO 2007 criteria. Immunostaining for p53 and Ki-67 markers were performed on 100 cases. RESULTS: There was female predominance. There were 194 Grade I, 24 Grade II and 6 Grade III meningiomas. Brain invasion noted in 18(8%) meningiomas predominantly in grade III followed by grade II. Recurrence was seen in 7 (3.1%) cases, most common in psammomatous followed by angiomatous meningioma. Immunostaining showed p53 positivity in 72.5% of grade I, 83.3% of grade II and all the cases of grade III tumours. Ki-67 Labelling Index (LI) consistently increased from grade I to grade III tumours. CONCLUSION:p53 and Ki-67 LI correlated well with increasing histological grade and biological behaviour of meningioma.
Entities:
Keywords:
Antigen; Central nervous system neoplasms; Primary intracranial tumours
Authors: H Kolles; I Niedermayer; C Schmitt; W Henn; R Feld; W I Steudel; K D Zang; W Feiden Journal: Acta Neurochir (Wien) Date: 1995 Impact factor: 2.216
Authors: Shun Zhang; Gloria Chia-Yi Chiang; Jacquelyn Marion Knapp; Christina M Zecca; Diana He; Rohan Ramakrishna; Rajiv S Magge; David J Pisapia; Howard Alan Fine; Apostolos John Tsiouris; Yize Zhao; Linda A Heier; Yi Wang; Ilhami Kovanlikaya Journal: J Neuroradiol Date: 2019-05-25 Impact factor: 3.447
Authors: Mariko D DeWire; Christine Fuller; Olivia Campagne; Tong Lin; Haitao Pan; Tina Young Poussaint; Patricia A Baxter; Eugene I Hwang; Andrew Bukowinski; Kathleen Dorris; Lindsey Hoffman; Angela J Waanders; Matthias A Karajannis; Clinton F Stewart; Arzu Onar-Thomas; Maryam Fouladi; Ira J Dunkel Journal: Clin Cancer Res Date: 2021-02-05 Impact factor: 12.531